{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:30:17Z","timestamp":1792074617624,"version":"4.4.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"This research project was supported by a grant from the research center of the Center for Female Scientific and Medical Colleges at King Saud University.","award":["------"],"award-info":[{"award-number":["------"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12944-016-0391-4","type":"journal-article","created":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T12:37:33Z","timestamp":1497530253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Increase of cytosolic phospholipase A2 as hydrolytic enzyme of phospholipids and autism cognitive, social and sensory dysfunction severity"],"prefix":"10.1186","volume":"16","author":[{"given":"Hanan","family":"Qasem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Al-Ayadhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussain","family":"Al Dera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afaf","family":"El-Ansary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,15]]},"reference":[{"key":"391_CR1","unstructured":"Gordan J. One in Every 50 Children Has Autism. UCLA Medical School CDC; 2013. http:\/\/www.huffingtonpost.com\/jay-gordon\/autismrates_b_2921256.html ."},{"key":"391_CR2","doi-asserted-by":"crossref","unstructured":"Ozonoff S, Iosif A-M, Baguio F, Cook IC, Hill MM, Hutman T, et al. A prospective study of the emergence of early behavioral signs of autism. J Am Acad Child Adolesc Psychiatry. 2010;49:256\u201366. e252.","DOI":"10.1016\/j.jaac.2009.11.009"},{"key":"391_CR3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ridd.2010.10.021","volume":"32","author":"L Klintwall","year":"2011","unstructured":"Klintwall L, Holm A, Eriksson M, Carlsson LH, Olsson MB, Hedvall O, et al. Sensory abnormalities in autism: a brief report. Res Dev Disabil. 2011;32:795\u2013800.","journal-title":"Res Dev Disabil"},{"key":"391_CR4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.mehy.2011.01.024","volume":"76","author":"CR King","year":"2011","unstructured":"King CR. A novel embryological theory of autism causation involving endogenous biochemicals capable of initiating cellular gene transcription: a possible link between twelve autism risk factors and the autism \u201a\u00c4\u00f2epidemic\u201a\u00c4\u00f4. Med Hypotheses. 2011;76:653\u201360.","journal-title":"Med Hypotheses"},{"key":"391_CR5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1086\/426951","volume":"76","author":"YJ Sung","year":"2005","unstructured":"Sung YJ, Dawson G, Munson J, Estes A, Schellenberg GD, Wijsman EM. Genetic investigation of quantitative traits related to autism: use of multivariate polygenic models with ascertainment adjustment. Am J Hum Genet. 2005;76:68\u201381.","journal-title":"Am J Hum Genet"},{"key":"391_CR6","doi-asserted-by":"crossref","first-page":"e883","DOI":"10.1371\/journal.pone.0000883","volume":"2","author":"MV Lombardo","year":"2007","unstructured":"Lombardo MV, Barnes JL, Wheelwright SJ, Baron-Cohen S. Self-referential cognition and empathy in autism. PLoS One. 2007;2:e883.","journal-title":"PLoS One"},{"key":"391_CR7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ridd.2007.08.003","volume":"29","author":"EB Itzchak","year":"2008","unstructured":"Itzchak EB, Lahat E, Burgin R, Zachor AD. Cognitive, behavior and intervention outcome in young children with autism. Res Dev Disabil. 2008;29:447\u201358.","journal-title":"Res Dev Disabil"},{"key":"391_CR8","unstructured":"Grandin T. Thinking in pictures, expanded edition: My life with autism. Vintage; 2009."},{"key":"391_CR9","unstructured":"Blackman L. Lucy\u2019s story: Autism and other adventures. England: Jessica Kingsley Publishers; 2001."},{"key":"391_CR10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1023\/B:JADD.0000006000.38991.a7","volume":"33","author":"SJ Rogers","year":"2003","unstructured":"Rogers SJ, Hepburn S, Wehner E. Parent reports of sensory symptoms in toddlers with autism and those with other developmental disorders. J Autism Dev Disord. 2003;33:631\u201342.","journal-title":"J Autism Dev Disord"},{"key":"391_CR11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5014\/ajot.61.2.190","volume":"61","author":"SD Tomchek","year":"2007","unstructured":"Tomchek SD, Dunn W. Sensory processing in children with and without autism: a comparative study using the short sensory profile. Am J Occup Ther. 2007;61:190\u2013200.","journal-title":"Am J Occup Ther"},{"key":"391_CR12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/02646830500381930","volume":"17","author":"CA Pardo","year":"2005","unstructured":"Pardo CA, Vargas DL, Zimmerman AW. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry. 2005;17:485\u201395.","journal-title":"Int Rev Psychiatry"},{"key":"391_CR13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.biopsych.2010.05.024","volume":"68","author":"JT Morgan","year":"2010","unstructured":"Morgan JT, Chana G, Pardo CA, Achim C, Semendeferi K, Buckwalter J, et al. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry. 2010;68:368\u201376.","journal-title":"Biol Psychiatry"},{"key":"391_CR14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/JCP.0b013e3181845f48","volume":"28","author":"TC Theoharides","year":"2008","unstructured":"Theoharides TC, Doyle R. Autism, gut-blood-brain barrier, and mast cells. J Clin Psychopharmacol. 2008;28:479\u201383.","journal-title":"J Clin Psychopharmacol"},{"key":"391_CR15","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1096\/fj.11-197194","volume":"26","author":"SD Skaper","year":"2012","unstructured":"Skaper SD, Giusti P, Facci L. Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J. 2012;26:3103\u201317.","journal-title":"FASEB J"},{"key":"391_CR16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","volume":"57","author":"DL Vargas","year":"2005","unstructured":"Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005;57:67\u201381.","journal-title":"Ann Neurol"},{"key":"391_CR17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pediatrneurol.2005.03.014","volume":"33","author":"AW Zimmerman","year":"2005","unstructured":"Zimmerman AW, Jyonouchi H, Comi AM, Connors SL, Milstien S, Varsou A, et al. Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol. 2005;33:195\u2013201.","journal-title":"Pediatr Neurol"},{"key":"391_CR18","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/ajcn\/80.6.1611","volume":"80","author":"SJ James","year":"2004","unstructured":"James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr. 2004;80:1611\u20137.","journal-title":"Am J Clin Nutr"},{"key":"391_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-7075-9-1","volume":"9","author":"PA Main","year":"2012","unstructured":"Main PA, Angley MT, O\u2019Doherty CE, Thomas P, Fenech M. The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis. Nutr Metab. 2012;9:1.","journal-title":"Nutr Metab"},{"key":"391_CR20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fphys.2014.00150","volume":"5","author":"DA Rossignol","year":"2014","unstructured":"Rossignol DA, Frye RE. Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Front Physiol. 2014;5:150.","journal-title":"Front Physiol"},{"key":"391_CR21","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1089\/ars.2010.3547","volume":"15","author":"V Chiurchiu","year":"2011","unstructured":"Chiurchiu V, Maccarrone M. Chronic inflammatory disorders and their redox control: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2011;15:2605\u201341.","journal-title":"Antioxid Redox Signal"},{"key":"391_CR22","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1582-4934.2008.00314.x","volume":"12","author":"D Farfara","year":"2008","unstructured":"Farfara D, Lifshitz V, Frenkel D. Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer\u2019s disease. J Cell Mol Med. 2008;12:762\u201380.","journal-title":"J Cell Mol Med"},{"key":"391_CR23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mrfmmm.2009.08.016","volume":"690","author":"S Fuller","year":"2010","unstructured":"Fuller S, Steele M, Munch G. Activated astroglia during chronic inflammation in Alzheimer\u2019s disease\u201a\u00c4\u00eedo they neglect their neurosupportive roles? Mutat Res. 2010;690:40\u20139.","journal-title":"Mutat Res"},{"key":"391_CR24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1196\/annals.1333.062","volume":"1043","author":"PI Moreira","year":"2005","unstructured":"Moreira PI, Smith MA, Zhu X, Nunomura A, Castellani RJ, Perry G. Oxidative stress and neurodegeneration. Ann N Y Acad Sci. 2005;1043:545\u201352.","journal-title":"Ann N Y Acad Sci"},{"key":"391_CR25","doi-asserted-by":"crossref","unstructured":"Melo A, Monteiro L, Lima RM, de Oliveira DgM, de Cerqueira MD, El-Bach RS. Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives. Oxid Med Cell Longev. 2011;2011:1\u201314.","DOI":"10.1155\/2011\/467180"},{"key":"391_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-1-14","volume":"1","author":"WJ Streit","year":"2004","unstructured":"Streit WJ, Mrak RE, Griffin WST. Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation. 2004;1:1.","journal-title":"J Neuroinflammation"},{"key":"391_CR27","unstructured":"Horrobin D, Bennett C. Phospholipid metabolism and the pathophysiology of psychiatric and neurological disorders. Phospholipid Spectr Dis Psychiatry Neurol. 2003:3\u201347."},{"key":"391_CR28","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature04399","volume":"438","author":"FR Maxfield","year":"2005","unstructured":"Maxfield FR, Tabas I. Role of cholesterol and lipid organization in disease. Nature. 2005;438:612\u201321.","journal-title":"Nature"},{"key":"391_CR29","volume-title":"Phospholipid spectrum disorders in psychiatry and neurology","author":"A Richardson","year":"2003","unstructured":"Richardson A. Phospholipid spectrum disorders in psychiatry and neurology. 2003."},{"key":"391_CR30","doi-asserted-by":"crossref","unstructured":"Morales I, Guzm\u221a\u00b0n-Mart\u221a\u2009\u2260\u2009nez L, Cerda-Troncoso Cb, Far\u221a\u2009\u2260\u2009as GA, Maccioni RB (2015) Neuroinflammation in the pathogenesis of Alzheimer\u201a\u00c4\u00f4s disease. A rational framework for the search of novel therapeutic approaches. 2015: Which new directions for Alzheimer\u2019s disease?","DOI":"10.3389\/fncel.2014.00112"},{"key":"391_CR31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1254\/jphs.08R01CR","volume":"108","author":"K Aoyama","year":"2008","unstructured":"Aoyama K, Watabe M, Nakaki T. Regulation of neuronal glutathione synthesis. J Pharmacol Sci. 2008;108:227\u201338.","journal-title":"J Pharmacol Sci"},{"key":"391_CR32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.plefa.2004.03.008","volume":"71","author":"J Bell","year":"2004","unstructured":"Bell J, MacKinlay E, Dick J, MacDonald D, Boyle R, Glen A. Essential fatty acids and phospholipase A 2 in autistic spectrum disorders. Prostaglandins Leukot Essent Fat Acids. 2004;71:201\u20134.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"391_CR33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.plefa.2009.06.003","volume":"81","author":"A Pastural","year":"2009","unstructured":"Pastural A, Ritchie S, Lu Y, Jin W, Kavianpour A, Su-Myat KK, et al. Novel plasma phospholipid biomarkers of autism: mitochondrial dysfunction as a putative causative mechanism. Prostaglandins Leukot Essent Fat Acids. 2009;81:253\u201364.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"391_CR34","doi-asserted-by":"crossref","first-page":"560","DOI":"10.5483\/BMBRep.2008.41.8.560","volume":"41","author":"RM Adibhatla","year":"2008","unstructured":"Adibhatla RM, Hatcher J. Phospholipase A2, reactive oxygen species, and lipid peroxidation in CNS pathologies. BMB Rep. 2008;41:560.","journal-title":"BMB Rep"},{"key":"391_CR35","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bbalip.2010.05.013","volume":"1801","author":"RO Sanchez-Mejia","year":"2010","unstructured":"Sanchez-Mejia RO, Mucke L. Phospholipase A 2 and arachidonic acid in Alzheimer\u2019s disease. Biochim Biophys Acta. 2010;1801:784\u201390.","journal-title":"Biochim Biophys Acta"},{"key":"391_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-10-1","volume":"10","author":"AK El-Ansary","year":"2011","unstructured":"El-Ansary AK, Bacha AGB, Al-Ayahdi LY. Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia. Lipids Health Dis. 2011;10:1.","journal-title":"Lipids Health Dis"},{"key":"391_CR37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0032-1301914","volume":"45","author":"M Tostes","year":"2012","unstructured":"Tostes M, Teixeira H, Gattaz W, Brand\u00e3o M, Raposo N. Altered neurotrophin, neuropeptide, cytokines and nitric oxide levels in autism. Pharmacopsychiatry. 2012;45:241\u20133.","journal-title":"Pharmacopsychiatry"},{"key":"391_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-14-83","volume":"14","author":"PM Hermann","year":"2013","unstructured":"Hermann PM, Park D, Beaulieu E, Wildering WC. Evidence for inflammation-mediated memory dysfunction in gastropods: putative PLA 2 and COX inhibitors abolish long-term memory failure induced by systemic immune challenges. BMC Neurosci. 2013;14:1.","journal-title":"BMC Neurosci"},{"key":"391_CR39","unstructured":"Mick KA. Diagnosing autism: Comparison of the childhood autism rating scale (CARS) and the autism diagnostic observation schedule (ADOS). Kansas: Wichita State University; 2005."},{"key":"391_CR40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1025014929212","volume":"33","author":"JN Constantino","year":"2003","unstructured":"Constantino JN, Davis SA, Todd RD, Schindler MK, Gross MM, Brophy SL, et al. Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised. J Autism Dev Disord. 2003;33:427\u201333.","journal-title":"J Autism Dev Disord"},{"issue":"6","key":"391_CR41","doi-asserted-by":"crossref","first-page":"608","DOI":"10.5014\/ajot.55.6.608","volume":"55","author":"W Dunn","year":"2001","unstructured":"Dunn W. The sensations of everyday life: empirical, theoretical, and pragmatic considerations. Am J Occup Ther. 2001;55(6):608\u201320.","journal-title":"Am J Occup Ther"},{"key":"391_CR42","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911\u20137.","journal-title":"Can J Biochem Physiol"},{"key":"391_CR43","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.lfs.2004.04.038","volume":"75","author":"A Chauhan","year":"2004","unstructured":"Chauhan A, Chauhan V, Brown WT, Cohen I. Oxidative stress in autism: Increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin - the antioxidant proteins. Life Sci. 2004;75:2539\u201349.","journal-title":"Life Sci"},{"key":"391_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-10-1","volume":"10","author":"AK El-Ansary","year":"2011","unstructured":"El-Ansary AK, Bacha AGB, Al-Ayadhi LY. Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia. Lipids Health Dis. 2011;10:1.","journal-title":"Lipids Health Dis"},{"key":"391_CR45","first-page":"578429","volume":"2013","author":"JC Hamlin","year":"2013","unstructured":"Hamlin JC, Pauly M, Melnyk S, Pavliv O, Starrett W, Crook TA, et al. Dietary intake and plasma levels of choline and betaine in children with autism spectrum disorders. Autism Res Treat. 2013;2013:578429.","journal-title":"Autism Res Treat"},{"key":"391_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-9-1","volume":"9","author":"A El-Ansary","year":"2012","unstructured":"El-Ansary A, Al-Ayadhi L. Neuroinflammation in autism spectrum disorders. J Neuroinflammation. 2012;9:1.","journal-title":"J Neuroinflammation"},{"key":"391_CR47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3844\/ajbbsp.2008.95.100","volume":"4","author":"A Chauhan","year":"2008","unstructured":"Chauhan A, Sheikh AM, Chauhan V. Increased copper-mediated oxidation of membrane phosphatidylethanolamine in autism. Am J Biochem Biotechnol. 2008;4:95\u2013100.","journal-title":"Am J Biochem Biotechnol"},{"key":"391_CR48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1054\/plef.2000.0186","volume":"63","author":"JG Bell","year":"2000","unstructured":"Bell JG, Sargent JR, Tocher DR, Dick JR. Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: a characteristic abnormality in neurodevelopmental disorders? Prostaglandins Leukot Essent Fatty Acids. 2000;63:21\u20135.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"391_CR49","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.clinbiochem.2009.03.011","volume":"42","author":"Y Al-Gadani","year":"2009","unstructured":"Al-Gadani Y, El-Ansary A, Attas O, Al-Ayadhi L. Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. Clin Biochem. 2009;42:1032\u201340.","journal-title":"Clin Biochem"},{"key":"391_CR50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1388-1981(00)00085-8","volume":"1487","author":"S Glozman","year":"2000","unstructured":"Glozman S, Cerruti-Harris C, Groner Y, Yavin E. Docosahexaenoic acid-deficient phosphatidyl serine and high \u0152\u2009\u00b1\u2009\u2212tocopherol in a fetal mouse brain over-expressing Cu\/Zn-superoxide dismutase. Biochim Biophys Acta. 2000;1487:135\u201344.","journal-title":"Biochim Biophys Acta"},{"key":"391_CR51","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.neuroscience.2009.09.062","volume":"164","author":"N Pandey","year":"2009","unstructured":"Pandey N, Sultan K, Twomey E, Sparks D. Phospholipids block nuclear factor-kappa B and tau phosphorylation and inhibit amyloid-beta secretion in human neuroblastoma cells. Neuroscience. 2009;164:1744\u201353.","journal-title":"Neuroscience"},{"key":"391_CR52","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.2010.06614.x","volume":"113","author":"RH Thomas","year":"2010","unstructured":"Thomas RH, Foley KA, Mepham JR, Tichenoff LJ, Possmayer F, MacFabe DF. Altered brain phospholipid and acylcarnitine profiles in propionic acid infused rodents: further development of a potential model of autism spectrum disorders. J Neurochem. 2010;113:515\u201329.","journal-title":"J Neurochem"},{"key":"391_CR53","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/0006-3223(93)90017-8","volume":"33","author":"NJ Minshew","year":"1993","unstructured":"Minshew NJ, Goldstein G, Dombrowski SM, Panchalingam K, Pettegrew JW. A preliminary 31P MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes. Biol Psychiatry. 1993;33:762\u201373.","journal-title":"Biol Psychiatry"},{"key":"391_CR54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1471-4159.2008.05347.x","volume":"106","author":"PB Shelat","year":"2008","unstructured":"Shelat PB, Chalimoniuk M, Wang J\u00c4, Strosznajder JB, Lee JC, Sun AY, et al. Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons. J Neurochem. 2008;106:45\u201355.","journal-title":"J Neurochem"},{"key":"391_CR55","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1073\/pnas.0605427104","volume":"104","author":"Y Shen","year":"2007","unstructured":"Shen Y, Kishimoto K, Linden DJ, Sapirstein A. Cytosolic phospholipase A2 alpha mediates electrophysiologic responses of hippocampal pyramidal neurons to neurotoxic NMDA treatment. Proc Natl Acad Sci. 2007;104:6078\u201383.","journal-title":"Proc Natl Acad Sci"},{"key":"391_CR56","doi-asserted-by":"crossref","first-page":"935608","DOI":"10.1155\/2013\/935608","volume":"2013","author":"M Careaga","year":"2013","unstructured":"Careaga M, Hansen RL, Hertz-Piccotto I, Van de Water J, Ashwood P. Increased anti-phospholipid antibodies in autism spectrum disorders. Mediators Inflamm. 2013;2013:935608.","journal-title":"Mediators Inflamm"},{"key":"391_CR57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ntt.2012.07.006","volume":"36","author":"PE Goines","year":"2013","unstructured":"Goines PE, Ashwood P. Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. Neurotoxicol Teratol. 2013;36:67\u201381.","journal-title":"Neurotoxicol Teratol"},{"key":"391_CR58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbi.2009.08.001","volume":"24","author":"AM Enstrom","year":"2010","unstructured":"Enstrom AM, Onore CE, Van de Water JA, Ashwood P. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun. 2010;24:64\u201371.","journal-title":"Brain Behav Immun"},{"key":"391_CR59","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbi.2010.08.003","volume":"25","author":"P Ashwood","year":"2011","unstructured":"Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun. 2011;25:40\u20135.","journal-title":"Brain Behav Immun"},{"key":"391_CR60","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1471-4159.2007.04861.x","volume":"103","author":"M Tsuda","year":"2007","unstructured":"Tsuda M, Hasegawa S, Inoue K. P2X receptors\u201a\u00c4\u00eamediated cytosolic phospholipase A2 activation in primary afferent sensory neurons contributes to neuropathic pain. J Neurochem. 2007;103:1408\u201316.","journal-title":"J Neurochem"},{"key":"391_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-015-0311-y","volume":"12","author":"M Khan","year":"2015","unstructured":"Khan M, Shunmugavel A, Dhammu TS, Matsuda F, Singh AK, Singh I. Oral administration of cytosolic PLA2 inhibitor arachidonyl trifluoromethyl ketone ameliorates cauda equina compression injury in rats. J Neuroinflammation. 2015;12:1.","journal-title":"J Neuroinflammation"},{"key":"391_CR62","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12017-009-8092-z","volume":"12","author":"GY Sun","year":"2010","unstructured":"Sun GY, Shelat PB, Jensen MB, He Y, Sun AY, Simonyi A. Phospholipases A2 and inflammatory responses in the central nervous system. Neruomol Med. 2010;12:133\u201348.","journal-title":"Neruomol Med"},{"key":"391_CR63","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1242\/jcs.02507","volume":"118","author":"D Zhu","year":"2005","unstructured":"Zhu D, Tan KS, Zhang X, Sun AY, Sun GY, Lee JC-M. Hydrogen peroxide alters membrane and cytoskeleton properties and increases intercellular connections in astrocytes. J Cell Sci. 2005;118:3695\u2013703.","journal-title":"J Cell Sci"},{"key":"391_CR64","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2174\/156802607780487623","volume":"7","author":"B Nanda","year":"2007","unstructured":"Nanda B, Nataraju A, Rajesh R, Rangappa K, Shekar M, Vishwanath B. PLA2 mediated arachidonate free radicals: PLA2 inhibition and neutralization of free radicals by anti-oxidants-a new role as anti-inflammatory molecule. Curr Top Med Chem. 2007;7:765\u201377.","journal-title":"Curr Top Med Chem"},{"key":"391_CR65","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.eurpsy.2011.05.004","volume":"27","author":"I Manor","year":"2012","unstructured":"Manor I, Magen A, Keidar D, Rosen S, Tasker H, Cohen T, et al. The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension. Eur Psychiatry. 2012;27:335\u201342.","journal-title":"Eur Psychiatry"},{"key":"391_CR66","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s10803-010-1005-z","volume":"40","author":"JL Taylor","year":"2010","unstructured":"Taylor JL, Seltzer MM. Changes in the autism behavioral phenotype during the transition to adulthood. J Autism Dev Disord. 2010;40:1431\u201346.","journal-title":"J Autism Dev Disord"},{"key":"391_CR67","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s10803-006-0307-7","volume":"37","author":"PT Shattuck","year":"2007","unstructured":"Shattuck PT, Seltzer MM, Greenberg JS, Orsmond GI, Bolt D, Kring S, et al. Change in autism symptoms and maladaptive behaviors in adolescents and adults with an autism spectrum disorder. J Autism Dev Disord. 2007;37:1735\u201347.","journal-title":"J Autism Dev Disord"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-016-0391-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T18:29:38Z","timestamp":1659119378000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-016-0391-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,15]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["391"],"URL":"https:\/\/doi.org\/10.1186\/s12944-016-0391-4","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,15]]},"article-number":"117"}}